Additionally, this research also sheds some light on the impact of STAT6 genetic variation on the EoE mechanism of action, which might open an avenue to its study as a diagnostic and pharmacogenetic biomarker. This evidence concerns the gene STAT6 and eosinophilic esophagitis.